Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

Dow, Nasdaq 100 and Nikkei 225 march higher

​​Indices have extended their rebound from last week’s lows, and enjoyed a strong session on Monday. Further gains seem likely as the positive seasonality of the fourth quarter begins to take hold. ​

Source: Bloomberg

​​​Dow at one-week high ​

The index surged on Monday, rallying back towards the 200-day simple moving average (SMA). ​ ​This comes after the gains made on Friday following the payrolls report. For the moment a low appears to be in place. Gains at the end of September faltered at the 200-day SMA and the 33,900 level, so a close above here would bolster the bullish view. From there, the 50-day SMA and then the 35,000 highs from August and September are the next targets. ​ ​Trendline resistance from the July high may prevent the price reaching the latter. A failure to close above the 200-day SMA and a move back below 33,500 might signal that a lower high is in place.

Source: ProRealTime

​Nasdaq 100 returns to 50-day moving average

Having spent last week defending the 14,500 level, the index has now pushed back towards the confluence of the 100- and 50-day SMAs. ​ ​A close above the latter targets trendline resistance from the July highs, and then from there the 15,500 level of late August and early September comes into view. This breakout above trendline resistance would then see the price take on a further bullish aspect, and then target the highs of July at 16,000. ​ ​Sellers will need a close back below 14,800 to suggest that another attempt to test support at 14,500 is in the offing.

Source: ProRealTime

​Nikkei 225 continues its rebound

​Last week witnessed the index rally from the 200-day SMA, and it has held its ground in trading so far this week. ​ ​All eyes are now on the 31,300 zone, to see if this low from August can be breached once more, which might then allow further bullish momentum to take the price on to the 50-day SMA, and then towards 33,000. ​ ​Sellers will need a reversal towards, and then a close below the 200-day SMA to provide a more bearish view. A close below last week’s low of 30,270 would reinforce this view.

Source: ProRealTime

Related articles

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.


This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.